Our results reveal differences in how terminal complement restricts Gc compared with other Gram-negative bacteria and help explain how terminal complement deficiencies uniquely sensitize individuals to Neisseria, suggesting novel host-targeting therapeutic approaches to help combat drug-resistant gonorrhea. Here, GC is linked to gonorrhea.